Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:50 AM
Ignite Modification Date:
2025-12-25 @ 4:50 AM
NCT ID:
NCT04753918
Eligibility Criteria:
Inclusion Criteria:
* Male or female aged between 20 and 75
* Diagnosed with histologically confirmed solid tumor located in the peripheral lung
* Not candidate or failed of standard chemotherapy, radiotherapy or surgery
* Primary lung cancer without mediastinal or distant lymph nodes metastasis (N0-N1)
* The tumor is ≤ 2 cm in size and clearly observable in computerized tomography (CT scan)
* Able to sign an informed consent
Exclusion Criteria:
* Diagnostic of small cell lung cancer or non-solid malignancy
* Solid tumor located in central lung
* Primary lung cancer without distant metastasis (M0)
* Received radiotherapy over the target tumor
* Abnormal blood results
* Received chemotherapy/immunotherapy in the last 4 weeks
* Tumor invasion with major blood vessels
* Allergy to porphyria or known hypersensitivity to Photofrin® or porphyrin-like compounds or to any of its excipients, allergy to Lipiodol or iodine-content contrast medium
* Planned surgical procedure within the next 90 days
* Coexisting ophthalmic disease likely to require slit-lamp examination within the next 90 days
* Acute or chronic medical or psychological illnesses that prevent endoscopy procedures
* Pregnant or intend to become pregnant, breastfeeding or intend to breastfeed during the study
* Received PDT during the past 1 months
* Severe impairment of your kidney or liver function
* Participates or intends to participate in another drug study (other than observational studies) during the study
* Victim of AIDS
* Other critical condition that the investigator considered not suited for participation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
75 Years
Study:
NCT04753918
Study Brief:
Protocol Section:
NCT04753918